What is Neuropace, Inc.'s compensation and benefits?

Neuropace, Inc. (NPCE) reported compensation and benefits of $7M in Q1 2026.

How has Neuropace, Inc.'s compensation and benefits changed year-over-year?

Neuropace, Inc.'s compensation and benefits increased by 18.4% year-over-year, from $5.91M to $7M.

What is the long-term trend for Neuropace, Inc.'s compensation and benefits?

Over 5 years (2020 to 2025), Neuropace, Inc.'s compensation and benefits has grown at a 18.1% compound annual growth rate (CAGR), from $4.57M to $10.49M.

Neuropace, Inc. NPCE Compensation and benefits

Compensation and benefits at other companies

StrykerSYK

$885M-3.7%

ClearPoint NeuroCLPT

——

Neurocrine BiosciencesNBIX

——

BiohavenBHVN

——

IDT CorporationIDT

——

Harmony Biosciences Holdings, Inc.HRMY

——

Other financials

Income statement

See full

Revenue$22.1M-2.0%

Gross profit$18.0M+4.1%

Operating income-$5.6M-8.2%

Net income-$6.7M-1.5%

EPS (diluted)-$0.20+4.8%

Balance sheet

See full

Cash & equivalents$15.6M-42.4%

Total debt$70.5M-3.7%

Total equity$14.5M-40.4%

Total assets$98.9M-10.3%

Cash flow

See full

Operating cash flow-$5.9M+21.1%

CapEx$117.0K+216%

Free cash flow-$6.0M+20.0%

Valuation

See full

Market cap$557.77M+63.4%

Enterprise value$612.6M+58.1%

P/S5.6×+1.6×

Profitability

See full

Gross margin78.3%+3.5pp

Operating margin-16.8%-3.5pp

Net margin-21.7%-4.5pp

FCF margin-10.3%-3.5pp

Returns & leverage

See full

Return on equity-111.4%-13.1pp

Debt / equity4.9×+1.9×

Current ratio5.4×-1.2×

Where this comes from

Reported directly by Neuropace, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neuropace, Inc.'s compensation and benefits?: Neuropace, Inc. (NPCE) reported compensation and benefits of $7M in Q1 2026.
How has Neuropace, Inc.'s compensation and benefits changed year-over-year?: Neuropace, Inc.'s compensation and benefits increased by 18.4% year-over-year, from $5.91M to $7M.
What is the long-term trend for Neuropace, Inc.'s compensation and benefits?: Over 5 years (2020 to 2025), Neuropace, Inc.'s compensation and benefits has grown at a 18.1% compound annual growth rate (CAGR), from $4.57M to $10.49M.